These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

833 related items for PubMed ID: 27055601

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and Safety of Relamorelin in Diabetics With Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
    Camilleri M, McCallum RW, Tack J, Spence SC, Gottesdiener K, Fiedorek FT.
    Gastroenterology; 2017 Nov; 153(5):1240-1250.e2. PubMed ID: 28760384
    [Abstract] [Full Text] [Related]

  • 3. Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.
    Camilleri M, Lembo A, McCallum R, Tourkodimitris S, Kemps L, Miller MB, Bertelsen K, Iacob A.
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1139-1148. PubMed ID: 32301137
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus.
    Shin A, Camilleri M, Busciglio I, Burton D, Smith SA, Vella A, Ryks M, Rhoten D, Zinsmeister AR.
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1453-1459.e4. PubMed ID: 23639598
    [Abstract] [Full Text] [Related]

  • 6. Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.
    Camilleri M, Acosta A.
    Neurogastroenterol Motil; 2015 Mar; 27(3):324-32. PubMed ID: 25545036
    [Abstract] [Full Text] [Related]

  • 7. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
    Talley NJ, Verlinden M, Geenen DJ, Hogan RB, Riff D, McCallum RW, Mack RJ.
    Gut; 2001 Sep; 49(3):395-401. PubMed ID: 11511562
    [Abstract] [Full Text] [Related]

  • 8. Relamorelin for the treatment of gastrointestinal motility disorders.
    Chedid V, Camilleri M.
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1189-1197. PubMed ID: 28847163
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.
    Parkman HP, Carlson MR, Gonyer D.
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1256-1263.e1. PubMed ID: 25576687
    [Abstract] [Full Text] [Related]

  • 14. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE, Crowell MD, Schettler-Duncan A, Mathis C, Pasricha PJ.
    Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
    [Abstract] [Full Text] [Related]

  • 15. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
    Carbone F, Van den Houte K, Clevers E, Andrews CN, Papathanasopoulos A, Holvoet L, Van Oudenhove L, Caenepeel P, Arts J, Vanuytsel T, Tack J.
    Am J Gastroenterol; 2019 Aug; 114(8):1265-1274. PubMed ID: 31295161
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of metoclopramide in diabetic gastroparesis.
    Ricci DA, Saltzman MB, Meyer C, Callachan C, McCallum RW.
    J Clin Gastroenterol; 1985 Feb; 7(1):25-32. PubMed ID: 3884697
    [Abstract] [Full Text] [Related]

  • 18. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
    Ejskjaer N, Wo JM, Esfandyari T, Mazen Jamal M, Dimcevski G, Tarnow L, Malik RA, Hellström PM, Mondou E, Quinn J, Rousseau F, McCallum RW.
    Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
    [Abstract] [Full Text] [Related]

  • 19. Diabetic gastroparesis.
    Koch KL, Calles-Escandón J.
    Gastroenterol Clin North Am; 2015 Mar; 44(1):39-57. PubMed ID: 25667022
    [Abstract] [Full Text] [Related]

  • 20. Investigational drug therapies for the treatment of gastroparesis.
    Sanger GJ, Pasricha PJ.
    Expert Opin Investig Drugs; 2017 Mar; 26(3):331-342. PubMed ID: 28127997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.